BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Saegis Pharmaceuticals, Inc. 

60 Stone Pine Road, Suite 200

Half Moon Bay  California  94019  U.S.A.
Phone: 650-560-0210 Fax: 650-560-0211


SEARCH JOBS


Industry
Pharmaceutical

Segment
Start Up





 Company News
With Trial Complete, Saegis Pharmaceuticals, Inc. Eyes Series D In 2006 12/30/2005 11:11:04 AM    More...
Saegis Pharmaceuticals, Inc. Completes Phase IIa Clinical Study Of SGS518 12/15/2005 11:29:30 AM    More...
Saegis Pharmaceuticals, Inc. Completes Phase I Clinical Study Of SGS518 10/19/2005 5:13:09 PM    More...
Saegis Pharmaceuticals, Inc. Initiates Phase II Clinical Trial Of SGS742 In Adult ADHD 10/19/2005 5:13:05 PM    More...
Saegis Pharmaceuticals, Inc. Appoints Ann Neale Vice President Of Clinical Operations 10/19/2005 5:12:28 PM    More...
Saegis Pharmaceuticals Names Jack M. Anthony Senior Vice President Of Business Development 10/19/2005 5:11:32 PM    More...
Saegis Pharmaceuticals Begins Phase II Clinical Trial Of SGS742 For Alzheimer's Disease 10/19/2005 5:11:10 PM    More...
Saegis Pharmaceuticals Announces Lead Product Candidate SGS742 Improves Cognition In Patients With Mild Cognitive Impairment; Mixed Results 10/19/2005 5:11:04 PM    More...
Saegis Pharmaceuticals Completes $30 Million Private Financing; Funding Supports Ongoing Clinical Development Of Novel Therapies For Alzheimer's Disease And Schizophrenia 10/19/2005 5:10:46 PM    More...
Saegis Pharmaceuticals, Inc. Receives $3.8 Million From The Stanley Medical Research Institute 10/19/2005 5:10:15 PM    More...
12

//-->